Search research articles
Contact Us
Filters
Showing results (161-170 of 187) with videos related to
Page
of 19
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2004
Critical factors for patient management
V Ninane, C Le Pechoux, W Curran, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 7, 2013
Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study
T Berghmans, L Ameye, L Willems, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2000
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party
J P Sculier, M Paesmans, J Thiriaux, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 1, 1996
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC)
M Borges, J P Sculier, M Paesmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2007
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer
J P Sculier, J J Lafitte, J Lecomte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2008
A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer
J P Sculier, J J Lafitte, A Efremidis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 23, 2007
Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy
M Vekemans, J Robinson, A Georgala, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 10, 2013
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
E de Azambuja, D Zardavas, M Lemort, et al.
British Journal of Cancer
|
November 27, 2001
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics
J P Sculier, M Paesmans, J Lecomte, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 27, 1999
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party
J P Sculier, M Paesmans, V Ninane, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 187) with videos related to
Sort By:
Page
of 19
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2004
Critical factors for patient management
V Ninane, C Le Pechoux, W Curran, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 7, 2013
Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study
T Berghmans, L Ameye, L Willems, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2000
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party
J P Sculier, M Paesmans, J Thiriaux, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 1, 1996
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC)
M Borges, J P Sculier, M Paesmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2007
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer
J P Sculier, J J Lafitte, J Lecomte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2008
A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer
J P Sculier, J J Lafitte, A Efremidis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 23, 2007
Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy
M Vekemans, J Robinson, A Georgala, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 10, 2013
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
E de Azambuja, D Zardavas, M Lemort, et al.
British Journal of Cancer
|
November 27, 2001
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics
J P Sculier, M Paesmans, J Lecomte, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 27, 1999
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party
J P Sculier, M Paesmans, V Ninane, et al.
Page
of 19